Fig. 4: Naive misclassification.
From: Overall survival after CDK4/6 inhibitor dose reduction in women with metastatic breast cancer

Kaplan–Meier, overall survival, a naive misclassification of dose reduction and b dose intensity.
From: Overall survival after CDK4/6 inhibitor dose reduction in women with metastatic breast cancer

Kaplan–Meier, overall survival, a naive misclassification of dose reduction and b dose intensity.